Dual roles and therapeutic potential of Keap1-Nrf2 pathway in pancreatic cancer: a systematic review

by Jiang-Jiang Qin, Xiang-Dong Cheng, Jia Zhang, Wei-Dong Zhang
Published 2019-09-01

Terphenyllin Suppresses Orthotopic Pancreatic Tumor Growth and Prevents Metastasis in Mice

by Jia Zhang, Jia Zhang, Weiyi Wang, Yuan Zhou, Jing Yang, Jingli Xu, Zhiyuan Xu, Zhiyuan Xu, Zhiyuan Xu, Beihua Xu, Li Yan, Xiang-Dong Cheng, Xiang-Dong Cheng, Xiang-Dong Cheng, Minghua Li, Jiang-Jiang Qin, Jiang-Jiang Qin, Jiang-Jiang Qin, Jiang-Jiang Qin
Published 2020-04-01

Identification of an Immune Gene-Associated Prognostic Signature and Its Association With a Poor Prognosis in Gastric Cancer Patients

by Xiaoqing Guan, Zhi-Yuan Xu, Runzhe Chen, Jiang-Jiang Qin, Xiang-Dong Cheng
Published 2021-02-01

Integrated Bioinformatics Analysis Reveals Key Candidate Genes and Pathways Associated With Clinical Outcome in Hepatocellular Carcinoma

by Yubin Li, Runzhe Chen, Runzhe Chen, Jian Yang, Shaowei Mo, Kelly Quek, Kelly Quek, Kelly Quek, Chung H. Kok, Chung H. Kok, Xiang-Dong Cheng, Xiang-Dong Cheng, Xiang-Dong Cheng, Saisai Tian, Weidong Zhang, Jiang-Jiang Qin, Jiang-Jiang Qin, Jiang-Jiang Qin, Jiang-Jiang Qin
Published 2020-07-01

Protein degradation technology: a strategic paradigm shift in drug discovery

by Haobin Li, Jinyun Dong, Maohua Cai, Zhiyuan Xu, Xiang-Dong Cheng, Jiang-Jiang Qin
Published 2021-09-01

Long non-coding RNAs towards precision medicine in gastric cancer: early diagnosis, treatment, and drug resistance

by Li Yuan, Zhi-Yuan Xu, Shan-Ming Ruan, Shaowei Mo, Jiang-Jiang Qin, Xiang-Dong Cheng
Published 2020-05-01

Synthesis, Characterization, Cellular Uptake, and In Vitro Anticancer Activity of Fullerenol-Doxorubicin Conjugates

by Beihua Xu, Li Yuan, Li Yuan, Ying Hu, Zhiyuan Xu, Jiang-Jiang Qin, Jiang-Jiang Qin, Xiang-Dong Cheng
Published 2021-01-01

Targeting MDMX for Cancer Therapy: Rationale, Strategies, and Challenges

by De-Hua Yu, Zhi-Yuan Xu, Shaowei Mo, Li Yuan, Xiang-Dong Cheng, Jiang-Jiang Qin, Jiang-Jiang Qin
Published 2020-08-01

PROTAC: An Effective Targeted Protein Degradation Strategy for Cancer Therapy

by Si-Min Qi, Jinyun Dong, Zhi-Yuan Xu, Xiang-Dong Cheng, Wei-Dong Zhang, Jiang-Jiang Qin, Jiang-Jiang Qin
Published 2021-05-01

Evaluation of D2-plus radical resection for gastric cancer with pyloric invasion

by Zhi-yuan Xu, Can Hu, Shangqi Chen, Yi-an Du, Ling Huang, Peng-fei Yu, Li-jing Wang, Xiang-dong Cheng
Published 2019-11-01

The Role of Autophagy in Gastric Cancer Chemoresistance: Friend or Foe?

by Jing-Li Xu, Jing-Li Xu, Jing-Li Xu, Li Yuan, Li Yuan, Li Yuan, Yan-Cheng Tang, Zhi-Yuan Xu, Zhi-Yuan Xu, Han-Dong Xu, Han-Dong Xu, Han-Dong Xu, Xiang-Dong Cheng, Xiang-Dong Cheng, Jiang-Jiang Qin, Jiang-Jiang Qin
Published 2020-12-01

Targeting β-Catenin Signaling by Natural Products for Cancer Prevention and Therapy

by Wen-Kai Yu, Zhi-Yuan Xu, Li Yuan, Shaowei Mo, Beihua Xu, Xiang-Dong Cheng, Jiang-Jiang Qin, Jiang-Jiang Qin
Published 2020-06-01

Targeting USP7-Mediated Deubiquitination of MDM2/MDMX-p53 Pathway for Cancer Therapy: Are We There Yet?

by Si-Min Qi, Gang Cheng, Xiang-Dong Cheng, Zhiyuan Xu, Beihua Xu, Wei-Dong Zhang, Wei-Dong Zhang, Jiang-Jiang Qin, Jiang-Jiang Qin
Published 2020-04-01

Exosomal miR-590-5p in Serum as a Biomarker for the Diagnosis and Prognosis of Gastric Cancer

by Guo-Dian Zheng, Zhi-Yuan Xu, Can Hu, Hang Lv, Hua-Xia Xie, Ting Huang, Yan-Qiang Zhang, Gui-Ping Chen, Yu-Fei Fu, Xiang-Dong Cheng
Published 2021-02-01